Monday, 10 April 2017
23andMe DNA test for Alzheimer’s risk approved for sale in US
The US Food and Drug Administration has given approval to the company 23andMe to market a spit test that assesses a person’s risk for 10 diseases via New Scientist - Health Read More Here..
Lake forest health and fitness http://ift.tt/2osoiX9
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment